PRTK - Paratek Pharamceuticals jumps amid report about takeover interest

2023-06-01 15:18:45 ET

• Paratek Pharmaceuticals ( NASDAQ: PRTK ) soared 16% amid a report about one of the potential private equity buyers for the biopharma company.
• Gurnet Point Capital is said to be one of the PE firms circling the company, according to a Betaville "rare" alert.
• The speculation comes after Betaville said in March that Paratek ( PRTK ) is a takeout target and that PE firms are the likely suitors.
• Paratek's ( PRTK ) marketed products include the antibiotics Nuzyra (omadacycline) and Seysara (sarecycline).
• Paratek ( PRTK ) reported Q1 results last month.

For further details see: